PatSnap Synapse

With PatSnap’s Synapse, life sciences professionals can seamlessly comb through and connect millions of early and late-stage drug discovery and development sources and make more informed decisions throughout every stage of the innovation cycle. Synapse automates ETL in real time on massive amounts of global biopharmaceutical-related data, combining natural language processing, machine learning and other artificial intelligence technologies to build a big data system from data monitoring, data mining to data applications. By the end of December 2022, the Synapse database contained 16 million+ pharmaceutical patents, 61 million+ literatures, 69,000+ new drugs, 44,000+ targets, 13,000+ indications, 340,000+ pharmaceutical institutions, 850,000+ clinical trials, 100,000+ pharmaceutical information and other data volumes.